Menu
While Kamala Harris has not been deeply involved in 340B matters, she has weighed in support of the program and urged action during various battles with the Trump administration.

A Closer Look at Kamala Harris’ Positions on 340B and Other Drug Pricing Issues  

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Vice President Kamala Harris’ quick rise this week to the top of the likely 2024 Democratic presidential ticket sparked renewed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

Just Days After Legal Setback, Novartis Exempts Mississippi Providers From Contract Pharmacy Restrictions

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live